--(BUSINESS WIRE)--BiOM is the leader in the field of personal bionics with the introduction of the first powered prosthetic device, BiOM T2. Privately held and headquartered in Bedford, Mass., BiOM was founded in 2007 by Dr. Hugh Herr, Director and Principal Investigator of the Biomechatronics Group of MIT’s Media Laboratory, and funded by leading investment firms including WFD Ventures, General Catalyst Partners, Sigma Partners, and Gilde Healthcare Partners.
The BiOM T2 technology emulates muscle function by powering dorsi and plantar flexion to allow people with lower leg amputations to walk with a more normalized gait, using less energy to walk at a normal preferred speed, and better able to navigate uneven terrain. These benefits may potentially reduce musculoskeletal stress believed to be the cause of co-morbidities associated with the use of prostheses including osteoarthritis. The company received funding and support from the U.S. Department of Veterans Affairs, and the U.S. Army’s Telemedicine and Advanced Technology Research Center (TATRC).
Company: |
BiOM | |
Headquarters Address: |
4 Crosby Drive | |
Bedford, MA 01730 | ||
Main Telephone: |
781.761.1560 | |
Website: |
||
Type of Organization: |
Private | |
Industry: |
Medical Devices | |
Key Executives: |
CEO: Charles Carignan |
|
Public Relations |
||
Contact: |
Kristen Smith | |
Phone: |
781.761.1558 | |
Email: |